Scientists have revealed nearly 100 genetic variants implicated in the development of cancers such as breast cancer and prostate cancer. The new method designed by the team identified these variants in the under-explored regions of DNA that do not code for proteins, but instead influence activity of other genes. As even more whole genome sequences become available, this approach can be applied to find any potential disease-causing variant in the non-coding regions of the genome.